Syneos Health, Inc. Stock
Equities
SYNH
US87166B1026
Biotechnology & Medical Research
Managers | Title | Age | Since |
---|---|---|---|
Colin Shannon
CEO | Chief Executive Officer | 65 | 23-09-27 |
Michael Bonello
DFI | Director of Finance/CFO | 55 | 23-06-30 |
Michael Brooks
COO | Chief Operating Officer | 50 | 21-07-13 |
Members of the board | Title | Age | Since |
---|---|---|---|
James Momtazee
BRD | Director/Board Member | 52 | 23-09-27 |
Colin Shannon
CEO | Chief Executive Officer | 65 | 23-09-27 |
James Dimitri
BRD | Director/Board Member | - | 23-09-27 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.82% | 8 M€ | +5.66% | ||
0.77% | 2 M€ | +10.27% | ||
0.50% | 0 M€ | 0.00% | - | |
0.36% | 0 M€ | 0.00% | - |
1st Jan change | Capi. | |
---|---|---|
-0.09% | 42.12B | |
+49.62% | 42.05B | |
-4.96% | 29.18B | |
+11.18% | 26.02B | |
-21.95% | 18.9B | |
+8.61% | 13.21B | |
+24.73% | 12.17B | |
+28.31% | 12.16B | |
-6.26% | 11.42B |